SearchCME LoginCE Login Show Cart
NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
CME Course Description
   
Login to view
Course Activities.

CME Live Virtual Conferences

Go Back




Title
: Emerging Challenges in Primary Care 2018 Houston, TX
Activity/Course #:
: 08.18.18PC

Cost:
: Free
Release/Start Date:
: Aug 18 2018
Expiration Date:
: Aug 18 2018
Topics:
: Primary Care Medicine
Target Audience:
: Primary Care Providers
Format:
: Live EC Primary Care
Estimated Time To Complete CME Activity:
: 7.0 hours
Credit(s):
: 7.0 AMA PRA Category I Credit(s)
7.0 AANP Contact hour(s) which includes 2.75 pharmacology hour(s)
Hardware/Software Requirements:
Saturday, August 18, 2018
Houston Marriott West Loop Hotel by the Galleria
1750 West Loop South
Houston, TX 77027
(713) 960-0111
 
Registration Fee
There is no registration fee for this activity.

Special Accommodations
NACE fully complies with the legal requirements of the Americans with Disabilities Act. Any activity registrant who feels s/he may need accommodations based on the impact of a disability should contact NACE to discuss your specific need.

Event Parking
A discounted self parking rate of $5.00 is available at the hotel. Valet parking is also available at the hotel for $17.00 per day.

Program Summary
Primary care providers face complex challenges everyday in their busy practices. With rapid changes in medicine, staying informed about new developments can be equally challenging. Our goal in this CME activity is to help you hone your skills in the diagnosis and management of patients with varied conditions you are likely encountering in your practice.

We have recruited a faculty of well-known thought leaders and experienced teachers who, as clinicians themselves, understand the challenges you face every day as a primary care provider. Our faculty will be at your disposal to provide evidence-based science, current treatment guidelines, discuss challenging cases, and provide answers for you that can ultimately lead to better health care for your patients. The presentations will include several interactive cases and discussion sessions to keep you actively learning.

Please join us and become an active participant in this one-day learning community of your peers.

Learning Objectives

At the conclusion of this program, participants should be able to:

1. Utilize evidence-based strategies to diagnose patients presenting with headache; Identify associated conditions (e.g. depression), and red flags for potentially life-threatening causes of headache; Use evidence-based recommendations to prescribe treatment for patients presenting with acute or emergent headache pain; Develop collaborate management plans, emphasizing patient education on avoiding triggers that cause headache, and adherence to prescribed treatment strategies; Discuss newer pharmacologic targets for managing patients with chronic migraine.

2. Discuss clinician and patient barriers to initiation and intensification of insulin therapy; Recognize the prevalence and clinical impact of hypoglycemia in special populations at risk; Discuss the pharmacology and clinical differences between existing and new long-acting and concentrated insulins; Discuss how to incorporate new basal and concentrated insulins into clinical practice while minimizing the risk of adverse events.

3. Recognize the importance of early identification of patients with potential idiopathic pulmonary fibrosis (IPF); Utilize appropriate strategies to diagnose a patient with IPF while excluding other potential mimickers; Discuss the available therapeutic options for patients with IPF; Recognize the role of the primary care clinician in managing the multi-morbidities associated with IPF.

4. Review the risk factors and classification of pulmonary hypertension (PH); Discuss the appropriate diagnostic strategy for pulmonary arterial hypertension (PAH), including the roles of echocardiography, ventilation/perfusion (V/Q) scanning, and right heart catheterization (RHC); Review current and emerging treatments for patients with PAH; Describe how to monitor patients with PAH for disease progression.

5. Describe the findings from recent trials of PCSK9i hypercholesterolemia treatments on cardiovascular outcomes; Discuss current guidelines and recommendations on the management of hyperlipidemia in high risk patients; Incorporate current data into secondary prevention treatment strategies for patients with the highest cardiovascular risk; Recognize barriers to access for PCSK9 monoclonal antibody therapy and discuss novel strategies to overcome them.

6. Understand sex-related differences in ischemic heart disease; Review novel ischemic syndromes in women; Recognize the relationship between breast cancer and heart disease.

 Agenda*

 7:30-8:00 

Continental Breakfast and Registration

8:00-8:10

 

Welcome Remarks
Deborah Paschal, CRNP

8:10-9:20

 

Managing Migraine: Primary Care for Primary Headaches
Jeff Unger, MD, FAAFP, FACE

     9:20-10:30

 

Safely Achieving Goals in Type 2 Diabetes (T2DM): The Role of Concentrated and Long-Acting Insulins
Jeff Unger, MD, FAAFP, FACE

10:30-10:50

 

Break

10:50-12:00

 

Navigating the Maze of Interstitial Lung Disease:Improving Outcomes through Early Diagnosis 
Franck Rahaghi, MD, MHS, FCCP

12:00-1:00

 

Lunch

1:00-2:10

 

Evolving Strategies of Care in Pulmonary Arterial Hypertension: Integrating the Data into Practice
Franck Rahaghi, MD, MHS, FCCP

2:10-3:20

 

Managing Lipids and Cardiovascular Risk: Using the Data to Optimize Care
Karol Watson, MD, PhD

3:20-3:30

 

Break

 3:30-4:40 Heart Disease in Women: Sex Matters
Karol Watson, MD, PhD

4:40-4:45

 

Program Summary and Closing Remarks
Deborah Paschal, CRNP

*Agenda subject to change.

Faculty

Deborah Paschal, CRNP
Clinical Nurse Practitioner
Philadelphia, PA

Franck Rahaghi, MD, MHS, FCCP
Director of Advanced Lung Disease Clinic
Director, Pulmonary Hypertension Clinic
Chairman, Dept. of Pulmonary and Critical Care
Cleveland Clinic Florida
Weston, FL

Jeff Unger, MD, FAAFP, FACE
Assistant Clinical Professor of Family Medicine
UC Riverside School of Medicine
Director, Unger Concierge Primary Care Medical Group
Rancho Cucamonga, CA

Karol E. Watson, MD, PhD
Professor of Medicine/Cardiology
Co-director, UCLA Program in Preventive Cardiology
Director, UCLA Barbra Streisand Women’s Heart Health Program
Los Angeles, CA

Planning Committee

Gregg Sherman, MD
Chief Medical Officer/Course Director
National Association for Continuing Education
Plantation, FL


Sheila Lucas, CWEP
Activity Director
National Association for Continuing Education

Plantation, FL

Sandy Bihlmeyer, M.Ed.
National Association for Continuing Education

Plantation, FL

Michelle Frisch, MPH, CHCP
National Association for Continuing Education

Plantation, FL

Cassandra A. McCullough, MBA

Chief Executive Officer

Association of Black Cardiologists

New York, NY

Harvey C. Parker, Ph.D., CHCP
National Association for Continuing Education

Plantation, FL

Sponsored and Certified By
National Association for Continuing Education & Association of Black Cardiologists, Inc.
Accreditation Designation Statement
The Association of Black Cardiologists, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Association of Black Cardiologists, Inc. designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The National Association for Continuing Education designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 7 contact hours of continuing education, which includes 2.75 pharmacology hours.
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the accredited providers to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the accredited providers are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships. Faculty disclosure will be provided in the activity materials.
Commercial Support
This activity is supported by educational funding provided by Amgen; a grant from Actelion Pharmaceuticals US, Inc.; an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.; an educational grant from Novo Nordisk Inc, an educational grant from Sanofi US and Regeneron Pharmaceuticals; and an educational grant from Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.